Bristol-Myers
Squibb Company (NYSE:BMY) will take part in the Citi 2017 Global
Healthcare Conference on Wednesday, December 6, 2017, in New York. Murdo
Gordon, chief commercial officer, will answer questions about the
company at 2:55 p.m. ET. Investors and the general public are invited to
listen to a live webcast of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Company Media:Ken Dominski, 609-252-5251 ken.dominski@bms.com or Investors:Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com